Zusammenfassung
Inzidenz: In der Bundesrepublik Deutschland rechnet man pro Jahr mit etwa 150 neudiagnostizierten Fällen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Beutler E (1992) Cladribine (2-chlorodeoxyadenosine). Lancet 340: 952–956
Bouroncle BA et al. (1958) Leukemic reticuloendotheliosis. Blood 13: 609–630
Braide I et al. (1991) Demonstrated benefit of continuous interferon alfa-2b therapy in hairy cell leukemia. A two years follow-up. Leukemia Lymphoma 5: 23–31
Calvo F et al. (1985) Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease. Blood 65: 115–119
Carson DA et al. (1984) Antileukemic and immunosuppressive activity of 2chlorodeoxyadenosine. Proc Natl Acad Sci USA 81: 2232–2236
Cassileth P et al. (1991) Pentostatin induces durable remissions in hairy cell leukemia. J Clin Oncol 9: 243–246
Catovsky D et al. (1987) Consensus resolution: proposed criteria for evaluation of response to treatment of hairy cell leukemia. Leukemia 1: 405–406
Cheson B. (1992) The purine analogs-a therapeutic beauty contest. J Clin Oncol 10: 352–355
Estey EH et al. (1992) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 79: 882–887
Foon KA et al. (1986) Response to 2’-deoxycoformycin after failure of interferon alpha in non-splenectomized patients with hairy cell leukemia. Blood 68: 297–300
Glaspy JA et al. (1988) Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 109: 789–795
Golomb HM et al. (1993) Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983–86. Leukemia 6: 1177–1180
Grever M et al. (1992) A randomized comparison of deoxycoformycin (DCF) versus alfa-2a interferon (IFN) in previuosly untreated patients with hairy cell leukemia (HCL): An NCI-sponsored Intergroup Study (SWOG, ECOG, CALGB, NCIT, CTG). Proc Am Soc Clin Oncol 11: 868
Hakimian D et al. (1993) Detection of residual minimal disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 82: 1798–1802
Ho AD et al. (1989) Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. J Clin Oncol 7: 1533–1538.
Jansen J et al. (1982) Clinical staging system for hairy cell leukemia Blood 60: 571–577
Juliusson G et al. (1992) Rapid recovery fom cytopenia in hairy cell leukemia (HCL) after treatment with 2-chloro-2’-deoxyadenosine (2-CdA) Blood 79: 888–894
Kantarjian HM et al. (1991) Fludarabine therapy in hairy cell leukemia. Cancer 67: 1291–293
Kraut E et al. (1986) Low-dose desoxycoformycin in the treatment of hairy cell leukemia Blood 68: 1119–1122
Liliemark J et al. (1992) On the bioavailability of oral and subcutaneous 2-chloro2’-deoxyadenosine in humans: alternative routes of administrations. J Clin Oncol 10: 1514–1518
Martin A et al. (1990) Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: Results of a phase II study. J Clin Oncol 8: 721–730
Nanba K et al. (1977) Splenic pseudosinuses and hepatic angiomatous lesions in hairy cell leukemia. Am J Clin Pathol 67: 451
Piro LD et al. (1990) Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322: 1117–1121
Pralle H et al. (1987) Primäre Behandlung der Haarzelleukämie mit niedrig-dosiertem humanen rekombinanten Interferon-Alpha2c (Hr-IFn Alpha 2c) im Vergleich zur Therapie nach Splenektomie. Onkologie 10: 5–10
Quesada JR et al. (1984) Alpha Interferon for induction of remission in hairy cell leukemia N Engl J Med 310: 15–17
Saven A et al. (1993) Complete remissions in hairy cell leukemia with 2’-Chlorodeoxyadenosin after failure with 2’-deoxycoformycin. Ann Intern Med 119: 278–283
Saven A et al. (1994) Drug therapy: Newer purine analogues for the treatment of hairy cell leukemia. N Engl J Med 330: 691–697
Schilsky RL et al. (1987) Gonodal and sexual function in male patients with hairy cell leukemia: Lack of adverse effects of recombinant A2-interferon treatment. Cancer Treatm Rep 71: 179–181
Steis RG et al. (1991) Loss of interferon antibodies during prolonged continuous interferon alfa-2a therapy in hairy-cell-leukemia. Blood 77: 792–795
Tallman MS et al. (1992) A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 80: 2203–2209
Norman et al. (1986) Splenectomy for Hairy Cell Leukemia. Cancer 57: 644–648
Zinzani PL et al. (1991) Comparison of Low-dose versus Standard-dose alpha Interferon Regimen in the Hairy cell Leukemia Treatment. Acta Haematol 85: 16–19
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pralle, H. (1997). Haarzelleukämie. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-12175-7_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60830-1
Online ISBN: 978-3-662-12175-7
eBook Packages: Springer Book Archive